Skip to main content

Table 5 The management of patients with 99mTc-3PRGD2 positive lesions and progressive disease after initial therapy and the results of the last follow-up

From: Evaluation of integrin αvβ3-targeted imaging for predicting disease progression in patients with high-risk differentiated thyroid cancer (using 99mTc-3PRGD2)

Disease status

Surgery (n = 10)

RAI (n = 2)

Targeted therapy (n = 2)

Complete cure

4

0

0

Clinical improvement

2

0

1

Stable disease

1

0

0

Progressive disease

3

2

0

Unknown

0

0

1

  1. Abbreviations: RAI radioactive iodine